Clinical Trial Update: Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating medical treatment of colitis in patients with Hermansky-Pudlak syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Hermansky-pudlak Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hermanski-Pudlak Syndrome, Colitis | Phase 2 | Status: WITHDRAWN